Schoch Charles

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 44% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Schoch Charles's trades of Candel Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-19 2025-03-17
PlS Planned sale
10,492 +5.6%
13.68
US$4,715,994 		10,492 +5.6% 13.68 US$4,715,994
2025-03-17 2025-03-17
PrS Proposed sale
5,190
437.27
US$4,302,397 		5,190 437.27 US$4,302,397
2025-01-17 2025-01-15
S Sale
10,680 +25.9%
220.85
US$1,665,828 		10,680 +25.9% 220.85 US$1,665,828
2025-01-15 2025-01-15
PrS Proposed sale
8,751
7.84
US$68,608 		8,751 7.84 US$68,608
2025-01-10 2025-01-08
S Sale
9,971 -15.9%
8.22
US$81,944 		9,971 -15.9% 8.22 US$81,944
2025-01-08 2025-01-08
PrS Proposed sale
9,801
8.35
US$81,838 		9,801 8.35 US$81,838
2024-07-19 2024-07-17
S Sale
9,884 -13.7%
6.47
US$63,975 		9,884 -13.7% 6.47 US$63,975
2024-07-17 2024-07-17
PrS Proposed sale
8,761
7.29
US$63,868 		8,761 7.29 US$63,868
2024-07-15 2024-07-11
S Sale
8,897 -10.9%
5.97
US$53,145 		8,897 -10.9% 5.97 US$53,145
2024-07-11 2024-07-11
PrS Proposed sale
8,754
5.92
US$51,824 		8,754 5.92 US$51,824